{
  "trial_id": "NCT00364000",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "more than 3 months on haemodialysis",
      "label": "unknown"
    },
    {
      "criterion": "willingness to participate",
      "label": "met"
    },
    {
      "criterion": "age 18-60 yrs",
      "label": "met"
    },
    {
      "criterion": "pre-dialysis blood pressure 120-160 mmHg in the last month prior to the initiation of study or recent (<1 Mo) addition of a new antihypertensive drug",
      "label": "unknown"
    },
    {
      "criterion": "iPTH at entry 200-800 pg/mL (as per severe hyperparathyroidism)",
      "label": "met"
    },
    {
      "criterion": "serum calcium at entry 2.2-2.6 mmol/L",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "haemodynamic instability",
      "label": "unknown"
    },
    {
      "criterion": "uncontrolled hypertension",
      "label": "triggers"
    },
    {
      "criterion": "any severe, debilitating disease associated with a reduced survival",
      "label": "unknown"
    },
    {
      "criterion": "any major cardiovascular event in the last 12 month before study",
      "label": "unknown"
    },
    {
      "criterion": "cinacalcet therapy before study entrance",
      "label": "unknown"
    },
    {
      "criterion": "history of parathyroidectomy",
      "label": "unknown"
    },
    {
      "criterion": "documented history of poor compliance",
      "label": "unknown"
    },
    {
      "criterion": "serious gastrointestinal disease",
      "label": "unknown"
    }
  ],
  "notes": "Patient has been treating with corticosteroid and cyclophosphamides for Wegener's granulomatosis since 4 months ago. His Birmingham Vasculitis Activity Score (BVAS) is above 4.",
  "_meta": {
    "topic_id": "54",
    "trial_id": "NCT00364000",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}